Philips has extended its partnership with Cortechs.ai, a pioneer in quantitative neuroimaging solutions.

The companies plan to integrate Cortechs.ai’s artificial intelligence (AI)-enabled neuroimaging into Philips’ MR systems to provide faster, more objective, and reproducible insights into brain health. Philips said the collaboration bolsters its leadership in precision neuro diagnostics, combining its next-gen MR technologies with Cortechs.ai’s AI-driven quantitative neuro imaging post-processing software to transform how neurological diseases are detected, monitored, and managed.

Current MR interpretation of neurodegenerative diseases or neuro oncology cases depends heavily on visual assessment, introducing variability and requiring significant expertise and time in an already overloaded system. The extended partnership aims to deliver more standardized and data-driven imaging.

Clinicians can gain objective, numerical data alongside images by integrating quantitative analysis tools like brain volumetrics, lesion quantification, and tumor tracking into the Philips MR imaging workflow. Combining Cortechs.ai’s NeuroQuant solutions for Alzheimer’s, MS, and brain tumors with Philips’ Smart Reading environment—a cloud-based AI platform the combines imaging, reading, and reporting on MR system—is a significant step toward precision neuroimaging.

“By extending our partnership with Cortechs.ai, we are accelerating the transition to fully quantitative, AI-powered neuroimaging,” said Ioannis Panagiotelis, Ph.D., business leader, MRI, Philips. “This integration brings precision, reproducibility, and efficiency to neurological MR, helping clinicians make faster, more confident decisions for patients living with complex brain conditions.”

Clinicians can automatically receive AI-generated quantitative reports in their standard MR workflow on the MR system of PACS without adding extra steps for technologists. A zero-click process ensures quality-checked data and standardized outputs.

By automatically generating quantitative reports within existing workflows, AI helps radiologists save time, improve consistency, and boost throughput. Objective numerical biomarkers enhance diagnostic accuracy, allowing more reproducible assessments and confident comparisons across time and sites.

Cortechs.ai’s  NeuroQuant solutions are already available on Philips Advanced Visualization Workspace.

“Cortechs.ai’s mission has always been to empower clinicians with actionable, quantitative insights,” said Kyle Frye, CEO of Cortechs.ai. “By combining our advanced neuro analytics with Philips’ leading MR platform and AI infrastructure, we’re making it easier to personalize brain care and track neurological changes with precision.”

Earlier this week, Philips introduced DeviceGuide, an AI-powered device tracking solution that assists physicians in repairing leaking heart valves through a minimally invasive approach.